{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:38:54Z","timestamp":1770968334799,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1997,3,1]],"date-time":"1997-03-01T00:00:00Z","timestamp":857174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1997,3]]},"DOI":"10.1007\/bf03346889","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T16:53:56Z","timestamp":1395939236000},"page":"122-127","source":"Crossref","is-referenced-by-count":11,"title":["Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man"],"prefix":"10.1007","volume":"20","author":[{"given":"E.","family":"Arvat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Maccagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ramunni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gianotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Di Vito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Deghenghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Camanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346889_CR1","first-page":"103","volume-title":"Regulation of growth hormone and somatic growth","author":"E Ghigo","year":"1992","unstructured":"Ghigo E. Neurotransmitter control of growth hormone secretion. In: De la Cruz L.F. (Ed.), Regulation of growth hormone and somatic growth. Excerpta Medica, Amsterdam, 1992, p. 103."},{"key":"BF03346889_CR2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/B978-0-12-510310-7.50011-9","volume-title":"Brain Messengers and the Pituitary","author":"EE M\u00fcller","year":"1989","unstructured":"M\u00fcller E.E., Nistic\u00f2 G. Neurotransmitter regulation of the anterior pituitary. In: M\u00fcller E.E., Nistic\u00f2 G. (Eds.), Brain Messengers and the Pituitary. Academic Press, Inc., San Diego, 1989, p. 404."},{"key":"BF03346889_CR3","first-page":"483","volume-title":"Endocrinology and Metabolism Clinics of North America","author":"FF Casanueva","year":"1992","unstructured":"Casanueva F.F. Physiology of growth hormone secretion and action. In: Melmed S. (Ed.), Endocrinology and Metabolism Clinics of North America. Saunders Company, Philadelphia, 1992, p. 483."},{"key":"BF03346889_CR4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1210\/jcem-43-3-582","volume":"3","author":"AE Pontiroli","year":"1976","unstructured":"Pontiroli A.E., Viberti G., Vicari A., Pozza G. Effects of the antihistamine agents meclastine and chlorpheniramine on the response of human GH to arginine infusion and insulin-hypoglycemia. Clin. Endocrinol. Metab. 3: 582, 1976.","journal-title":"Clin. Endocrinol. Metab."},{"key":"BF03346889_CR5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00427953","volume":"80","author":"A Penalva","year":"1983","unstructured":"Penalva A., Villanueva L., Casanueva F.F., Cavagnini F., Gomez Pan A., M\u00fcller E.E. Cholinergic and histaminergic involvement in growth hormone releasing effect of an enkephalin analogue (FK33-824). Psychopharmacology 80: 120, 1983.","journal-title":"Psychopharmacology"},{"key":"BF03346889_CR6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-2007-996233","volume":"12","author":"AE Pontiroli","year":"1980","unstructured":"Pontiroli A.E., Pellicciotta G., Alberetto M., DeCastro e Silva E., DePasqua A., Girardi A.M., Pozza G. Repeated Cimetidine administration reduces the Growth Hormone (GH) response to insulin-hypoglycemia. Horm. Metab. Res. 12: 172, 1980.","journal-title":"Horm. Metab. Res."},{"key":"BF03346889_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2265.1981.tb00648.x","volume":"15","author":"TW Valk","year":"1981","unstructured":"Valk T.W., England B.C., Marshall J.C. Effects of Cimetidine on pituitary function: alteration in hormone secretion profiles. Clin. Endocrinol. (Oxf.) 15: 139, 1981.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03346889_CR8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jcem-55-1-118","volume":"55","author":"U Knigge","year":"1982","unstructured":"Knigge U., Dejgaard A., Wollesen F., Thuesen B., Christiansen P.M. Histamine regulation of prolactin secretion through H1 and H2 histamine receptors. J. Clin. Endocrinol. Metab. 55: 118, 1982.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346889_CR9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/acta.0.1240609","volume":"124","author":"U Knigge","year":"1991","unstructured":"Knigge U., Warberg J. The role of histamine in the neuroendocrine regulation of pituitary hormone secretion. Acta Endocrinol. (Copenh) 124: 609, 1991.","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"BF03346889_CR10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-45-2-367","volume":"45","author":"HE Carlson","year":"1977","unstructured":"Carlson H.E., Ippoliti A.F. Cimetidine, an H2-antihistamine, stimulates prolactin secretion in man. Clin. Endocrinol. Metab. 45: 367, 1977.","journal-title":"Clin. Endocrinol. Metab."},{"key":"BF03346889_CR11","first-page":"717","volume":"1","author":"WL Burland","year":"1978","unstructured":"Burland W.L., Gleadle R.I., Lee R.M., Rowley J.D. Cimetidine and serum prolactin. Br. Med. J. 1: 717, 1978.","journal-title":"Br. Med. J."},{"key":"BF03346889_CR12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/pgmj.56.657.478","volume":"56","author":"GF Nelis","year":"1980","unstructured":"Nelis G.F., Van de Maen J.G.C. Comparative effects of Cimetidine and ranitidine on prolactin secretion. Postgrad. Med. J. 56: 478, 1980.","journal-title":"Postgrad. Med. J."},{"key":"BF03346889_CR13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1530\/acta.0.0970098","volume":"97","author":"B Allolio","year":"1981","unstructured":"Allolio B., Winkelmann W., Hipp F.X. Effect of meclastine, an H-1 antihistamine, on plasma ACTH in adrenal insufficiency. Acta Endocrinol. (Copenh.) 97: 98, 1981.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03346889_CR14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.1983.tb02986.x","volume":"19","author":"B Allolio","year":"1983","unstructured":"Allolio B., Deuss U., Kaulen D., Winkelmann W. Effects of meclastine, a selective H1 receptor antagonist, upon ACTH release. Clin. Endocrinol. (Oxf.) 19: 239, 1983","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03346889_CR15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-4612-2396-2_27","volume-title":"Growth hormone secretagogues","author":"E Ghigo","year":"1996","unstructured":"Ghigo E., Arvat E., Gianotti L, Grottoli S., Rizzi G., Ceda G.P., Deghenghi R., Camanni F. Aging and GH-releasing peptides. In: Bercu B., Walker R. (Eds.), Growth hormone secretagogues. Serono Symposia, New York, 1996, p. 415."},{"key":"BF03346889_CR16","first-page":"203","volume-title":"Growh hormone II, basic and clinical aspects","author":"CY Bowers","year":"1993","unstructured":"Bowers C.Y., Veeraragavan K., Sethumadahavan K. Atipical growth hormone releasing peptides. In: Bereu B.B., Walker R.F. (Eds.), Growh hormone II, basic and clinical aspects. Springer-Verlag, New York, 1993, p. 203."},{"key":"BF03346889_CR17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/jcem-70-4-975","volume":"70","author":"CY Bowers","year":"1990","unstructured":"Bowers C.Y., Reynolds G.A., Durham D., Barrera CM., Pezzoli S.S., Thorner M.O. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Clin. Endocrinol. Metab. 70: 975, 1990.","journal-title":"Clin. Endocrinol. Metab."},{"key":"BF03346889_CR18","first-page":"168","volume":"76","author":"A Penalva","year":"1993","unstructured":"Penalva A., Carballo A., Pombo M., Casanueva F.F., Dieguez C. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. Clin. Endocrinol. Metab. 76: 168, 1993.","journal-title":"Clin. Endocrinol. Metab."},{"key":"BF03346889_CR19","first-page":"693","volume":"78","author":"E Ghigo","year":"1994","unstructured":"Ghigo E., Arvat E., Gianotti L., Imbimbo B.P., Lenaerts V., Deghenghi P., Camanni F. Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man. Clin. Endocrinol. Metab. 78: 693, 1994.","journal-title":"Clin. Endocrinol. Metab."},{"key":"BF03346889_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000126827","volume":"61","author":"E Arvat","year":"1995","unstructured":"Arvat E., Gianotti L., Di Vite L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 61: 51, 1995.","journal-title":"Neuroendocrinology"},{"key":"BF03346889_CR21","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1126\/science.8503009","volume":"260","author":"RG Smith","year":"1993","unstructured":"Smith R.G., Cheng K., Pong S.S., Hickey G., Jacks T., Butler B., Chan W.W., Chaung L.Y.P., Judith F., Taylor F.J., Wyvratt M.J., Fisher M.H. A non-peptidyl GH secretagogue. Science 260: 1640, 1993.","journal-title":"Science"},{"key":"BF03346889_CR22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1677\/joe.0.1430399","volume":"143","author":"T Jacks","year":"1994","unstructured":"Jacks T., Hickey G., Judith F., Taylor J., Chen H., Krupa D., Feeney W., Schoen W., Ok D., Fisher M., Wyvratt M., Smith R. Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, Cortisol, prolactin, insulin, and thyroxine levels in beagles. J. Endocrinol. 143: 399, 1994.","journal-title":"J. Endocrinol."},{"key":"BF03346889_CR23","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1210\/endo.136.3.7867560","volume":"136","author":"CH Chang","year":"1995","unstructured":"Chang CH., Rickes E.L., Marsilio F., McGuire L., Cosgrove S., Taylor J, Chen S., Feighner S., Clark J.N., De Vita R., Schoen W., Wyvratt M., Fisher M., Smith R.G., Hickey G.J. Activity of a novel non peptidyl GH secretagogue, L-700,653, in swine. Endocrinology 136: 1065, 1995.","journal-title":"Endocrinology"},{"key":"BF03346889_CR24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1210\/endo.134.2.8299565","volume":"134","author":"GJ Hickey","year":"1994","unstructured":"Hickey G.J., Jacks T., Judith F., Taylor J., Schoen W.R., Krupa D., Cunningham P., Clark J., Smith R.G. Efficacy and specificity of L-692,429, a novel non-peptidyl growth hormone secretagogue, in beagles. Endocrinology 134: 695, 1994.","journal-title":"Endocrinology"},{"key":"BF03346889_CR25","first-page":"1393","volume":"77","author":"BJ Gertz","year":"1993","unstructured":"Gertz B.J., Barrett J.S., Eisenhandler R., Krupa D.A., Wittreich J.M., Seibold J.R., Schneider S.M. Growth hormone response in man to L-692,429, a novel non peptide mimic of growth hormone-releasing peptide-6. J. Clin. Endocrinol. Metab. 77: 1393, 1993.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346889_CR26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF00191904","volume":"46","author":"BP Imbimbo","year":"1994","unstructured":"Imbimbo B.P., Mant T., Edward M., Amin D., Froud A., Lenaerts V, Boutignon F., Deghenghi R. Growth hormone-releasing activity of hexarelin in humans: a dose-response study. Eur.J. Clin.Pharmacol. 46: 421, 1994.","journal-title":"Eur.J. Clin.Pharmacol."},{"key":"BF03346889_CR27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2265.1995.tb02045.x","volume":"43","author":"M Korbonits","year":"1995","unstructured":"Korbonits M., Trainer P.J., Besser G.M. The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin. Endocrinol. (Oxf.) 43: 365, 1995.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03346889_CR28","first-page":"2776","volume":"81","author":"G Copinschi","year":"1996","unstructured":"Copinschi G., van Ondergen A., L\u2019hermite-Baleriaux M., Mendel C.M., Caufriez A., Leproult R., Thorner M.O. Effects of 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J. Clin. Endocrinol. Metab. 81: 2776, 1996.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346889_CR29","unstructured":"Deghenghi R., Boutignon F., Wuthrich P., Lenaerts V., Imbimbo B., Lucchelli P.E., Locatelli V., Battisti C., Cananzi M., M\u00fcller E.E. GH releasing properties of hexarelin (EP 23905). International Symposium on Growth Hormone II: Basic and Clinical Aspects, Tarpon Springs, Florida, p. 31 (Abstract), 1992."},{"key":"BF03346889_CR30","unstructured":"Muccioli G., Gh\u00e8 C, Ghigo M.C., Arvat E., Papotti M., Boghen M.F., Deghenghi R., Ong H., Ghigo E. Presence of specific receptors for Hexarelin, a GH releasing hexapeptide, in human brain and pituitary gland. Intemational symposium Growth Factors in Endocrinology and Metabolism, Berlin, p. 110 (Abstract), 1995."},{"key":"BF03346889_CR31","volume-title":"The pharmacological basis of therapeutics","author":"Goodman","year":"1975","unstructured":"Goodman and Gilman\u2019s. The pharmacological basis of therapeutics, ed 7. Macmillan Publ. Comp., New York, 1975.","edition":"7"},{"key":"BF03346889_CR32","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1159\/000124602","volume":"43","author":"F Massara","year":"1986","unstructured":"Massara F., Ghigo E., Demislis K., Tangolo D., Mazza E., Locatelli V., M\u00fcller E.E., Camanni F. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release. Studies in normal and acromegalic subjects. Neuroendocrinology 43: 670, 1986.","journal-title":"Neuroendocrinology"},{"key":"BF03346889_CR33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0026-0495(95)90300-3","volume":"44","author":"M Maccario","year":"1995","unstructured":"Maccario M., Arvat E., Procopio M., Gianotti L., Grottoli S., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F. Metabolic modulation of the growth-hormone-releasing activity of hexarelin in man. Metabolism 44: 134, 1995.","journal-title":"Metabolism"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346889\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:11:52Z","timestamp":1565309512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["BF03346889"],"URL":"https:\/\/doi.org\/10.1007\/bf03346889","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}